Probiotics

News Watch

When in love, we get butterflies in our stomach or if the nerves really hit before taking an exam, we might get diarrhea. Our brain and gut are in constant contact as we undergo experiences in our daily lives. The gut, for instance, sends information to the brain about what we eat, if we have enough nutrients to stay healthy…

GMFH Editing Team
GMFH Editing Team

When in love, we get butterflies in our stomach or if the nerves really hit before taking an exam, we might get diarrhea. Our brain and gut are in constant contact as we undergo experiences in our daily lives. The gut, for instance, sends information to the brain about what we eat, if we have enough nutrients to stay healthy…

GMFH Editing Team
GMFH Editing Team

Since Dutchman Antony van Leeuwenhoek discovered bacteria and protozoa for the first time ever in history in the 17th century, much has been learnt about the microscopic world we live in and the one that lives inside us. Our microbiota, and specially our gut microbiota, have been studied intensely over the past 15 years. A huge amount of data is…

Cristina Sáez
Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

Since Dutchman Antony van Leeuwenhoek discovered bacteria and protozoa for the first time ever in history in the 17th century, much has been learnt about the microscopic world we live in and the one that lives inside us. Our microbiota, and specially our gut microbiota, have been studied intensely over the past 15 years. A huge amount of data is…

Cristina Sáez
Cristina Saez is a freelance science journalist. She works for several media, for instance the Spanish newspaper La Vanguardia, where she coordinates the science section, Big Vang; as well as research centres and scientific societies. She has been awarded for her journalistic work, among others, with the Boehringer Ingelheim Award in Medical Journalism 2015. Follow Cristina on Twitter @saez_cristina

Akkermansia muciniphila. Despite the tricky moniker, keep this name in mind, because it is the next generation of promising probiotics coming from your gut microbiota. Yes, you have got it right. Recent studies have already shed light on the bunch of positive effects it has on our overall health. For instance, during the last Gut Microbiota for Health World Summit,…

GMFH Editing Team
GMFH Editing Team

Akkermansia muciniphila. Despite the tricky moniker, keep this name in mind, because it is the next generation of promising probiotics coming from your gut microbiota. Yes, you have got it right. Recent studies have already shed light on the bunch of positive effects it has on our overall health. For instance, during the last Gut Microbiota for Health World Summit,…

GMFH Editing Team
GMFH Editing Team

During the 7th Gut Microbiota for Health World Summit 2018, held in Rome, we had the opportunity to talk to Andrea Hardy, Registered Dietitian from Calgary (Canada), about the role of the dietitians and nutritionists as gut health ambassadors. “I would like to press people to think of gut health as being for everybody," states Hardy. In the interview, the dietitian…

GMFH Editing Team
GMFH Editing Team

During the 7th Gut Microbiota for Health World Summit 2018, held in Rome, we had the opportunity to talk to Andrea Hardy, Registered Dietitian from Calgary (Canada), about the role of the dietitians and nutritionists as gut health ambassadors. “I would like to press people to think of gut health as being for everybody," states Hardy. In the interview, the dietitian…

GMFH Editing Team
GMFH Editing Team

A growing number of scientific studies show diet can affect health through the gut microbiota. “By modulating your diet, you can also modulate your microbes. Microbes can contribute to the severity or the onset of a disease. But if your diet is wrong or unhealthy, that is the first cause,” highlights Clara Belzer. Food and dietary patterns actually have differing…

GMFH Editing Team
GMFH Editing Team

A growing number of scientific studies show diet can affect health through the gut microbiota. “By modulating your diet, you can also modulate your microbes. Microbes can contribute to the severity or the onset of a disease. But if your diet is wrong or unhealthy, that is the first cause,” highlights Clara Belzer. Food and dietary patterns actually have differing…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Looking for a review that covers all the bases of probiotic health effects? A new, open access paper may serve that purpose. “Probiotics for human use” is a peer-reviewed paper published by the Nutrition Bulletin. This was a collaborative effort by experts in clinical effects (Prof. Dan Merenstein MD from Georgetown University, Claire Merrifield PhD from Imperial College London), fermented…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

Looking for a review that covers all the bases of probiotic health effects? A new, open access paper may serve that purpose. “Probiotics for human use” is a peer-reviewed paper published by the Nutrition Bulletin. This was a collaborative effort by experts in clinical effects (Prof. Dan Merenstein MD from Georgetown University, Claire Merrifield PhD from Imperial College London), fermented…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

The administration of broad-spectrum antibiotics is an important risk factor for Clostridium difficile infection (CDI) in the Western world. Recent research has suggested that probiotics may help reduce the incidence of C. difficile-associated diarrhea (CDAD) among children and adults in both hospital and outpatient settings. A new systematic review and meta-analysis, led by Dr. Bradley Johnston from Dealhousie University (Canada),…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

The administration of broad-spectrum antibiotics is an important risk factor for Clostridium difficile infection (CDI) in the Western world. Recent research has suggested that probiotics may help reduce the incidence of C. difficile-associated diarrhea (CDAD) among children and adults in both hospital and outpatient settings. A new systematic review and meta-analysis, led by Dr. Bradley Johnston from Dealhousie University (Canada),…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

On June 5-7, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened its annual meeting, for the first time in Asia. The program featured two days of open plenary sessions attended by 230 academic and industry scientists, health professionals, and regulatory representatives. A third day of discussion groups was held for invited experts and Industry Advisory Committee members, while…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

On June 5-7, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened its annual meeting, for the first time in Asia. The program featured two days of open plenary sessions attended by 230 academic and industry scientists, health professionals, and regulatory representatives. A third day of discussion groups was held for invited experts and Industry Advisory Committee members, while…

Mary Ellen Sanders
Mary Ellen Sanders is a consultant in the area of probiotic microbiology, with special expertise on paths to scientific substantiation of probiotic product label claims. Dr. Sanders served as the founding president of the International Scientific Association for Probiotics and Prebiotics (ISAPP) and is currently the organization’s Director of Scientific Affairs/ Executive Officer. This international, non-profit association of academic and industrial scientists is dedicated to advancing the science of probiotics and prebiotics (www.isapp.net). Through numerous written, oral and video pieces, including a website, www.usprobiotics.org, she strives to provide objective, evidence-based information on probiotics for consumers and professionals. Key activities include: Panels to determine GRAS status of probiotic strains ; member of the American Gastroenterological Association Scientific Advisory Board for AGA Center for Gut Microbiome Research and Education ; World Gastroenterology Organisation Committee preparing practice guidelines for the use of probiotics and prebiotics for GI indications (2008, 2011, 2014) ; working group convened by the FAO/WHO that developed guidelines for probiotics (2002).

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close intersection between health and disease. As a result, the number of publications discussing the gut microbiota over the past five years represents more than 80%…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

New developments in genetics and metagenomics over the past 15 years have led scientists to produce an in-depth characterization of the composition and function of the gut microbiome as a novel organ in the close intersection between health and disease. As a result, the number of publications discussing the gut microbiota over the past five years represents more than 80%…

Patrice D. Cani
Professor Patrice D. Cani is researcher from the Belgian Fund for Scientific Research (FRS-FNRS), group leader in the Metabolism and Nutrition research group at the Louvain Drug Research Institute (LDRI) from the Université catholique de Louvain (UCL), Brussels, Belgium, and WELBIO (Walloon Excellence in Lifesciences and BIOtechnology) investigator. He is currently member of several international associations, he is member of the Alumni College from the Royal Belgian Academy of Sciences, and he has been elected in the board of directors of the LDRI (UCL). Patrice D. Cani has a M.Sc. in Nutrition and another M.Sc. in health Sciences, he is registered dietitian and PhD in Biomedical Sciences. His main research interests are the investigation of the role of the gut microbiota in the development of metabolic disorders, such as obesity, type 2 diabetes and low grade inflammation. More specifically, he is investigating the interactions between the gut microbiota, the host and specific biological systems such as the endocannabinoid system and the innate immune system in the context of obesity, type 2 diabetes and metabolic inflammation. Prof Cani is author and co-author of more than 110 scientific research papers published in peer-reviewed international journals, conferences and book chapters.

Previous data in animals and humans have shown the potential of manipulating the gut microbiome to modify emotional and cognitive behavior and brain function. For instance, Bifidobacterium longum 1714 has been tested for central effects in mice and humans, but studies assessing how probiotics may affect behavior and brain function in healthy volunteers are scarce. A new double-blind, placebo-controlled randomized…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Previous data in animals and humans have shown the potential of manipulating the gut microbiome to modify emotional and cognitive behavior and brain function. For instance, Bifidobacterium longum 1714 has been tested for central effects in mice and humans, but studies assessing how probiotics may affect behavior and brain function in healthy volunteers are scarce. A new double-blind, placebo-controlled randomized…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.